Genomelabs Bio Company

Genomelabs is a young entrant in the healthcare sector that focuses on the physical well-being and quality of life of individuals by offering a holistic model of wellness.They offer a unique portfolio of products and formulations that support wellness and prevention across a broad range of therapeutic areas. They also have an extensive pipeline of promising new products that have the potential to prevent some of the most feared diseases of our times. Moreover as a "vertically integrated" company, they cover the entire span of a products life cycle from the process of manufacturing, marketing, distributing, and selling that product – from beginning to end. Genomelabs' mission is to offer the best remedies to enhance human health by using the marvels of contemporary scientific healthcare and develop the most innovative, reliable and assured quality products that help consumers stay fit and prevent ailments and illnesses. Their vision is to deliver the highest level of physical, social, and mental well-being within the society and they want to break the barriers in healthcare by creating effective and affordable formulations for consumers across different socio-economic classes.


Connections from

Technology: Prevention Programs
Headquarters: Others
Last Funding Type: Non-equity Assistance
Founded Date: 2016-01-01
Investors Number: 1
Industry: NeuroTech
Investor Type: For Profit